Competing commitments in clinical trials.

Scholars of the ethics of clinical trials have long recognized a tension between the therapeu tic obligations1 of clinicians (physi cian, nurses, and other health pro fessionals) and the scientific demands of clinical trials.2 The basis for this concern is clear: clini cal care is focused on improving the condition of the presenting patient, while clinical research seeks valid, generalizable informa tion to help future patients. Although in principle both the investigational and control arms of clinical trials are designed to have an equal likelihood of efficacy for the typical patient, in many situa tions research and clinical goals may nonetheless be in conflict. For example, during the recruitment process for a clinical trial, clini cians may have to decide whether to offer participation to a patient who might benefit from the study intervention, but who does not meet the trial's eligibility require ments.3 And once a patient enrolls in a trial, clinicians have to decide whether to deviate from protocol requirements (e.g., dosage of study medication, use of adjunctive med ications, or procedures to collect required study data) for the pur pose of promoting the patient-sub ject's best medical interests. Finally,

[1]  D. Dillman Mail and internet surveys: The tailored design method, 2nd ed. , 2007 .

[2]  K. Oberle,et al.  Ethical Considerations for Nurses in Clinical Trials , 2006, Nursing ethics.

[3]  D. Healy,et al.  Interface between authorship, industry and science in the domain of therapeutics , 2003, British Journal of Psychiatry.

[4]  Max Lagnado,et al.  Increasing the trust in scientific authorship , 2003, British Journal of Psychiatry.

[5]  D. Rosenstein,et al.  The therapeutic orientation to clinical trials. , 2003, The New England journal of medicine.

[6]  J. Cameron,et al.  Scientific Datafrom Clinical Trials: Investigators' Responsibilities and Rights , 2002, Diseases of the colon and rectum.

[7]  J. Cameron,et al.  Scientific Data from Clinical Trials: Investigators’ Responsibilities and Rights , 2002, Journal of pediatric surgery.

[8]  R Peto,et al.  Trials: the next 50 years , 1998, BMJ.

[9]  M. Rankin,et al.  Perceptions of scientific misconduct in nursing. , 1997, Nursing research.

[10]  F. Gifford Community-equipoise and the ethics of randomized clinical trials. , 1995, Bioethics.

[11]  K. Taylor,et al.  Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Redmond,et al.  Fraud in breast-cancer trials. , 1994, The New England journal of medicine.

[13]  R Peto,et al.  Large-scale randomized evidence: large, simple trials and overviews of trials. , 1993, Annals of the New York Academy of Sciences.

[14]  R. Glass,et al.  Cancer clinical trials. , 2004, Seminars in oncology nursing.

[15]  W Wood,et al.  Selection bias in clinical trials. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Winn,et al.  An evaluation of physician determinants in the referral of patients for cancer clinical trials in the community setting. , 1984, Progress in clinical and biological research.

[17]  D. Marquis,et al.  Leaving therapy to chance. , 1983, The Hastings Center report.

[18]  J. Marks,et al.  Recruitment of patients to cooperative group clinical trials. , 1980, Cancer clinical trials.